Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Hanlan Liu, Jayaprakasam Bolleddula, Andrew Nichols, Lei Tang, Zhiyang Zhao & Chandra Prakash. (2020) Metabolism of bioconjugate therapeutics: why, when, and how?. Drug Metabolism Reviews 52:1, pages 66-124.
Read now
Read now
Articles from other publishers (18)
Sureshbabu Ram Kumar Pandian, Panneerselvam Theivendren, Vigneshwaran Ravishankar, Parasuraman Pavadai, Sivakumar Vellaichamy, Ponnusamy Palanisamy, Murugesan Sankaranarayanan & Selvaraj Kunjiappan. 2022. Engineered Nanomaterials for Innovative Therapies and Biomedicine. Engineered Nanomaterials for Innovative Therapies and Biomedicine
343
372
.
Cristina Martín-Sabroso, Ana Isabel Torres-Suárez, Mario Alonso-González, Ana Fernández-Carballido & Ana Isabel Fraguas-Sánchez. (2021) Active Targeted Nanoformulations via Folate Receptors: State of the Art and Future Perspectives. Pharmaceutics 14:1, pages 14.
Crossref
Crossref
Ruo Wang. (2021) Anticancer activities, structure–activity relationship, and mechanism of action of 12‐, 14‐, and 16‐membered macrolactones. Archiv der Pharmazie 354:9, pages 2100025.
Crossref
Crossref
Tarun Kumar Patel, Nilanjan Adhikari, Sk. Abdul Amin, Swati Biswas, Tarun Jha & Balaram Ghosh. (2021) Small molecule drug conjugates (SMDCs): an emerging strategy for anticancer drug design and discovery. New Journal of Chemistry 45:12, pages 5291-5321.
Crossref
Crossref
Rongjun He, Jia Pan, John P. Mayer & Fa Liu. (2020) The Chemical Methods of Disulfide Bond Formation and Their Applications to Drug Conjugates. Current Organic Chemistry 23:25, pages 2802-2821.
Crossref
Crossref
Urvi H. Gala, Dave A. Miller & Robert O. WilliamsIIIIII. (2020) Harnessing the therapeutic potential of anticancer drugs through amorphous solid dispersions. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1873:1, pages 188319.
Crossref
Crossref
Kathleen N Moore, Lainie P Martin, David M O'Malley, Ursula A Matulonis, Jason A Konner, Ignace Vergote, Jose F Ponte & Michael J Birrer. (2018) A review of mirvetuximab soravtansine in the treatment of platinum-resistant ovarian cancer. Future Oncology 14:2, pages 123-136.
Crossref
Crossref
Daniel Merk & Manfred Schubert-Zsilavecz. 2017. Drug Selectivity. Drug Selectivity
207
245
.
Ludger A. Wessjohann, Richard Bartelt & Wolfgang Brandt. 2017. Practical Medicinal Chemistry with Macrocycles. Practical Medicinal Chemistry with Macrocycles
77
100
.
Klaudia Siwowska, Raffaella Schmid, Susan Cohrs, Roger Schibli & Cristina Müller. (2017) Folate Receptor-Positive Gynecological Cancer Cells: In Vitro and In Vivo Characterization. Pharmaceuticals 10:4, pages 72.
Crossref
Crossref
K. C. Nicolaou, Derek Rhoades, Yanping Wang, Ruoli Bai, Ernest Hamel, Monette Aujay, Joseph Sandoval & Julia Gavrilyuk. (2017) 12,13-Aziridinyl Epothilones. Stereoselective Synthesis of Trisubstituted Olefinic Bonds from Methyl Ketones and Heteroaromatic Phosphonates and Design, Synthesis, and Biological Evaluation of Potent Antitumor Agents. Journal of the American Chemical Society 139:21, pages 7318-7334.
Crossref
Crossref
Jose F. Ponte, Olga Ab, Leanne Lanieri, Jenny Lee, Jennifer Coccia, Laura M. Bartle, Marian Themeles, Yinghui Zhou, Jan Pinkas & Rodrigo Ruiz-Soto. (2016) Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha–Targeting Antibody-Drug Conjugate, Potentiates the Activity of Standard of Care Therapeutics in Ovarian Cancer Models. Neoplasia 18:12, pages 775-784.
Crossref
Crossref
Anthony Cheung, Heather J. Bax, Debra H. Josephs, Kristina M. Ilieva, Giulia Pellizzari, James Opzoomer, Jacinta Bloomfield, Matthew Fittall, Anita Grigoriadis, Mariangela Figini, Silvana Canevari, James F. Spicer, Andrew N. Tutt & Sophia N. Karagiannis. (2016) Targeting folate receptor alpha for cancer treatment. Oncotarget 7:32, pages 52553-52574.
Crossref
Crossref
Nuria de Mas, Donald C. Kientzler & Devon Kleindienst. (2015) Endotoxin Removal from a Small-Molecule Aqueous Drug Substance Using Ultrafiltration: A Case Study. Organic Process Research & Development 19:9, pages 1293-1298.
Crossref
Crossref
Ignace Vergote & Christopher P. Leamon. (2015) Vintafolide: a novel targeted therapy for the treatment of folate receptor expressing tumors. Therapeutic Advances in Medical Oncology 7:4, pages 206-218.
Crossref
Crossref
Madduri Srinivasarao, Chris V. Galliford & Philip S. Low. (2015) Principles in the design of ligand-targeted cancer therapeutics and imaging agents. Nature Reviews Drug Discovery 14:3, pages 203-219.
Crossref
Crossref
Christian Bailly. (2013) Cell-targeted cytotoxics: a new generation of cytotoxic agents for cancer treatment. Phytochemistry Reviews 13:1, pages 171-181.
Crossref
Crossref
Bingbing Wang, Chris V Galliford & Philip S Low. (2014) Guiding principles in the design of ligand-targeted nanomedicines. Nanomedicine 9:2, pages 313-330.
Crossref
Crossref